Recent patents related to p53

被引：0
|
作者：
机构：
来源：
Nature Reviews Drug Discovery | 2014年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：169 / 169
相关论文
共 50 条
  • [21] Understanding p53 functions through p53 antibodies
    Sabapathy, Kanaga
    Lane, David P.
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2019, 11 (04) : 317 - 329
  • [22] Regulation of p53 and p53 family members.
    Prives, C
    Ahn, J
    DiComo, C
    Gaiddon, C
    Shieh, S
    FASEB JOURNAL, 1999, 13 (07): : A1430 - A1430
  • [23] The p53 network: p53 and its downstream genes
    Shu, Kun-Xian
    Li, Biao
    Wu, Li-Xiang
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2007, 55 (01) : 10 - 18
  • [24] How the p53 mRNA controls p53 activity
    Malbert-Colas, Laurence
    Tournillon, Anne-Sophie
    Olivares-Illana, Vanesa
    Punnuswainy, Anand
    Fahraeus, Robin
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 30 : S20 - S20
  • [25] Computational protein chemistry of p53 and p53 peptides
    Brandt-Rauf, PW
    Rosal, RV
    Fine, RL
    Pincus, MR
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 2778 - 2787
  • [26] Modulation of alternative splicing contributes to cancer development: focusing on p53 isoforms, p53β and p53γ
    Solomon, H.
    Sharon, M.
    Rotter, V.
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (09): : 1347 - 1349
  • [27] P53 α-helix mimetics antagonize p53/MDM2 interaction and activate p53
    Chen, LH
    Yin, H
    Farooqi, B
    Sebti, S
    Hamilton, AD
    Chen, JD
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (06) : 1019 - 1025
  • [28] Modulation of alternative splicing contributes to cancer development: focusing on p53 isoforms, p53β and p53γ
    H Solomon
    M Sharon
    V Rotter
    Cell Death & Differentiation, 2014, 21 : 1347 - 1349
  • [29] Enhanced sensitivity to CDDP related to p53 overexpression in a hepatocellular carcinoma cell line with wild type p53
    Nakayama, D
    Magami, Y
    Furukawa, M
    Moriyasu, F
    Sakai, T
    GASTROENTEROLOGY, 2002, 122 (04) : A650 - A651
  • [30] p53 protein expression in non-Hodgkin's lymphomas is infrequently related to p53 gene mutations
    Oka, T
    Sarker, AB
    Teramoto, N
    Yoshino, T
    Akagi, T
    PATHOLOGY INTERNATIONAL, 1998, 48 (01) : 15 - 21
12345